Clinical Pharmacology Study of CS-3150 Drug-drug interaction Study between CS-3150 and digoxin or rifampicin in healthy Japanese subjects.

Trial Profile

Clinical Pharmacology Study of CS-3150 Drug-drug interaction Study between CS-3150 and digoxin or rifampicin in healthy Japanese subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Esaxerenone (Primary) ; Digoxin; Rifampicin
  • Indications Diabetic nephropathies; Essential hypertension; Hyperaldosteronism; Hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 24 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 09 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 28 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top